baber/WOPTO huggingface dataset:
Patent SG-43964-A1 (SG)
Title: Improved shroud and cleaning apparatus incorporating an improved shroud
Inventor: DYSON JAMES
IPC: B04C11/00
Filed: 1991-12-03
Abstract: A shroud for use in a dual inner and outer cyclonic vacuum cleaner (10) is described. The shroud has a cylindrical section (50c, 132) adjacent an inner surface 15b, 111b) of a cyclonic container (15,111) and preferably comprises a combined shroud disc unit (50). The combined shroud and disc unit fits on the outside surface (20c) of the inner cyclone (20) and aids in removal of first and fibrous matter from the airflow in the outer cyclone (15). Improved airflow between the outer cyclone (15) and inner cyclone (20) is achieved because of the shroud and disc unit (50). <IMAGE>
Patent SG-165137-A1 (SG)
Title: Electronic bill presentment and/or payment clearinghouse
Inventor: GANESAN RAVI
IPC: G06Q20/40
Filed: 2000-04-06
Abstract: Network stations are used to electronically pay bills. Each station represents a different user, including payers and payees. Each user has a payment account maintained at one of a plurality of different financial institutes. An instruction to make payment of a bill of a payee is received, via a network, from a user station representing a payer. A directive, directing a transfer of funds from the payment account associated with the payer and maintained at a first financial institute to a deposit account associated with the payee and maintained at a second financial institute, is generated based on the received payment instruction. Remittance information associated with payment of the bill by the fund transfer is also generated. The directive is transmitted to the first financial institute. The remittance information is stored in a central database so as to be accessible, via the network, to a user station representing the payee.
Patent SG-141257-A1 (SG)
Title: Apparatus and method for demodulating a modulated signal
Inventor: QING XU CHANG
Filed: 2006-09-12
Abstract: APPARATUS AND METHOD FOR DEMODULATING A MODULATED SIGNAL An apparatus for demodulating a modulated signal comprises an analog to digital converter for converting an analog modulated input signal to a digital signal. The analog to digital converter is arranged to sample the input signal at a predetermined sampling rate. A digital down converter then receives the digital signal at the sampling rate. The digital down converter has an associated digital intermediate frequency and reduces the frequency of the digital signal from the predetermined sampling rate to the digital intermediate frequency which is one quarter of the sampling rate. A low pass filter filters selected frequencies from the digital signal. A frequency offset stage applies a modification to the frequency of the filtered signal to reduce frequency offset therein, and a differential demodulator demodulates the signal after modifying the frequency to reduce the frequency offset. There is also disclosed a method for demodulating a signal.
Patent WO-2007139515-A1 (WO)
Title: Casque d'écoute hybride sans fil
Inventor: HUI SIEW KOK
IPC: H04R5/033
Filed: 2007-05-29
Abstract: Cette invention concerne un dispositif électronique sans fil destiné à la transmission et au traitement de signaux sonores. Dans un mode de réalisation, le dispositif électronique sans fil comprend une unité principale portée sur une oreille d'un utilisateur, laquelle unité principale comprend un circuit électrique principal conçu pour recevoir, traiter et transmettre des signaux sonores. Les signaux sonores peuvent être transmis par différentes sources. Le dispositif électronique sans fil comprend également un microphone électroniquement couplé au circuit électrique principal afin de fournir les signaux sonores traités à un utilisateur; un microphone est électroniquement couplé au circuit électrique principal; une interface est électroniquement couplé au circuit électrique principal afin de permettre une connexion à un raccord secondaire; et une source d'alimentation permettant d'alimenter le dispositif électronique sans fil. Lorsque l'interface n'est pas connectée avec le raccord secondaire, le dispositif électronique fonctionne comme un casque d'écoute monophonique
Patent SG-157974-A1 (SG)
Title: An image capturing apparatus able to be draped on a stand and a method for providing an image with eye-to-eye contact with a recipient
Inventor: FUI CHONG KIN
Filed: 2008-06-18
Abstract: There is provided an image capturing apparatus able to be draped onto a stand. The apparatus includes an image capture module for capturing at least one image; and a flexible cable originating from the image capture module for connection of the image capture module to a host. The flexible cable may be for supporting the image capture module at a desired position when the image capturing apparatus is draped onto the stand. Advantageously, locating the image capture module at the desired position enables a user to look at a lens of the image capture module in a manner where a recipient of an image of the user views the user looking directly at the recipient during a video conference session. In a second aspect, there is provided a method for enabling a user to appear to be looking directly at a recipient of an image of the user, wherein an image capturing module is located at least a pre- determined distance above a head of an image of the recipient such that the user is able to continually look at the image of the recipient while the user's head movements are captured by the image capturing module.
Patent SG-155192-A1 (SG)
Title: System and method for effectuating a sip call in a network environment including ims
Inventor: BUCKLEY ADRIAN
IPC: H04W8/26
Filed: 2007-01-10
Abstract: SYSTEM AND METHOD FOR EFFECUTATING A SIP CALL IN A NETWORK ENVIRONMENT INCLUDING IMS In one embodiment, a scheme is disclosed for routing a Session Initiation Protocol (SIP) call in a network environment (100) including a circuit- switched (CS) network and an IP multimedia subsystem (IMS) network (112). When a SIP call is originated by a user equipment (UE) device (302) in the CS network domain, call information associated with the call is provided to an application server (AS) node (114-N) disposed in the IMS network (112). At the AS node (114-N), a pool of E. 164 numbers are maintained as IP multimedia routing numbers (IMRNs) which are mapped to or otherwise associated with called party SIP URIs. The AS node (114-N) dynamically allocates a select IMRN with respect to a called party's SIP URI received from the UE device (302) and returns it to the UE device (302). The dynamically allocated IMRN is then utilized for routing the SIP call towards the called party.
Patent SG-166790-A1 (SG)
Title: System, method and apparatus for self-cleaning dry etch
Inventor: III ANDREW D BAILEY
IPC: H01L33/00
Filed: 2004-12-30
Abstract: A method for cleaning a processing chamber that includes heating an inner surface of the processing chamber to a first temperature. The first temperature can be sufficient to cause a first species to become volatile. The first species can be one of several species deposited on the innver surface. A cleaning chemistry is injected into the processing chamber. The cleaning chemistry can be reactive with a second one of the species to convert the second species to the first species. The volatilized first species can also be output from the processing chamber. A system for cleaning the process chamber is also described. Figures 3A and 3B
Patent SG-174939-A1 (SG)
Title: Valve of a hydraulic door actuating device
Inventor: WILDFOERSTER THOMAS
Filed: 2010-05-19
Abstract: The invention relates to a valve (1) for a hydraulic door actuating device. The door actuating device is set up for opening and/or closing a connected door, and comprises a housing (13). The valve (1) is set up in the housing (13) of the door actuating device for influencing a flow of hydraulic fluid (H) in the door actuating device. The valve (1) comprises a sleeve (2) and a slide (3) longitudinally displaceably guided in the sleeve (2) and pretensioned by a return spring (4) in the direction of a longitudinal axis (L) of the sleeve (2). The slide (3) comprises a thrust surface (5) contacting a counter edge (6) implemented on the sleeve (2) due to the action of the return spring (4), and thereby blocks the flow of hydraulic fluid (H), and is designed for being acted on mechanically and externally against the action of the return spring (4). The invention further relates to a door actuating device having such a valve, set up for hydraulically opening and/or closing a connected door, and a housing (13) and a hydraulic circuit, through which the hydraulic fluid is forced when the door actuating device performs an opening or closing motion. The valve (1) is integrated in the hydraulic circuit of the door actuating device, such that it blocks the flow of hydraulic fluid (H) in the hydraulic circuit due to the action of the return spring (4). The slide (3) is acted on mechanically by an actuating device (24) of the door actuating device during the opening or closing motion thereof, and is thereby forced away from the counter edge (6) in the direction of the return spring (4).
Patent SG-176274-A1 (SG)
Title: Two component etching
Inventor: DOLL OLIVER
Filed: 2010-05-12
Abstract: The object of the present invention is a new inkjet printable etching composition comprising an etchant, which is activated by a second component. Thus, a further object is the use of this new composition in a process for the etching of surfaces semiconductor devices or surfaces of solar cell devices.
Patent SG-179083-A1 (SG)
Title: Pharmaceutically useful heterocycle-substituted lactams
Inventor: HADDACH MUSTAPHA
Filed: 2010-09-10
Abstract: The invention provides compounds that inhibit CK2 and/or Pim kinases and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, infections, and certain immunological disorders.
Patent SG-181509-A1 (SG)
Title: Animal model expressing luciferase under control of the myelin basic protein promoter (mbp-luci) and use of the model for bioluminescence in vivo imaging
Inventor: CAO JAMES
Filed: 2010-12-03
Abstract: A Myelin Basic Protein-luciferase bioimaging noninvasive model to visualize and quantify demyelination and remyelination events in the CNS at transcriptional level in vivo is provided. Luciferase-expressing transgenic animals were generated with myelin basic protein (MBP) promoter coupled to firefly luciferase reporter. The MBP-luci bioimaging model provides a means to monitor myelination status and the efficacy of a remyelination modulating test compound. An advantage of bioimaging is that a subject in a longitudinal study can serve as its own control. The same subject can be tracked over a demyelination and remyelination process continuously over a period of at least 10 weeks. This model enables normalization of individual animal imaging response and provides quality data with considerably reduced variance. In addition, because cohorts of animals need not be sacrificed at different time points, reduction in the number necessary for a compound efficacy study is possible.
Patent SG-183802-A1 (SG)
Title: Low temperature curing polyuretdione compositions
Inventor: SHAFFER MYRON W
Filed: 2011-03-15
Abstract: Composition and process for low temperature curing of polyuretdione-polyol compositions in which the polyuretdione is prepared from a polyisocyanate with isocyanate groups and a polyol containing primary hydroxyl groups. The catalyst for the composition and process is an amine catalyst containing the group -N=C-N-, being aprotic, having a pKa greater than 20 and upon addition to the liquid coating composition causing a phase-change of the coating composition from liquid to solid at 250C and 1atm. within one week.
Patent SG-183735-A1 (SG)
Title: Milnacipran for the long-term treatment of fibromyalgia syndrome
Inventor: RAO SRINIVAS G
Filed: 2006-09-27
Abstract: MILNACIPRAN FOR THE LONG-TERM TREATMENT OF FIBROMYALGIA SYNDROME The present invention is directed to methods for providing long-term treatment of fibromyalgia syndrome (FMS) by administering a dual re-uptake inhibitor to a patient with FMS. More particularly, the present invention is directed to the long-term treatment of FMS by administering a norepinephrine-serotonin reuptake inhibitor (NSRI) to a patient with FMS.
Patent SG-185593-A1 (SG)
Title: Long - acting formulations of insulins
Inventor: BECKER REINHARD
Filed: 2011-05-18
Abstract: The application relates to an aqueous pharmaceutical formulation comprising 200 – 1000 U/mL [equimolar to 200 –1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.
Patent SG-187544-A1 (SG)
Title: Methods and compositions for liver cancer therapy
Inventor: HOUHOU LEILA
Filed: 2011-07-22
Abstract: The present disclosure provides methods of treating liver cancer and preventing liver cancer recurrence with anti-progastrin antibodies, methods of monitoring treatment efficacy of anti-progastrin therapy for liver cancer, and compositions useful therefore.
Patent SG-187889-A1 (SG)
Title: A slewing apparatus
Inventor: NYGAARD STIG ANDRE
Filed: 2011-08-25
Abstract: A slewing apparatus, comprising a slewing bearing means for the operation of a reel. A first slewing bearing (10) is configured to carry torsion and axial loads in the reel, while the second slewing bearing (20) is configured not to carry substantial torsion and axial loads in the reel. Thereby the second slewing bearing (20) functions as a back-up bearing for the reel, while the first slewing bearing (10) operates the reel and thus serves as the primary slewing bearing for the reel.
Patent SG-194352-A1 (SG)
Title: Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
Inventor: MANGANO DENNIS T
Filed: 2006-03-28
Abstract: 5The present invention provides methods, compositions, formulations, and kits related to acadesine, or a prodrug, analog, or salt thereof, and/or a blood dotting inhibitor for preventing adverse effects in a patient. The type of patient that my benefit includes a patient with decreased left ventricular function, a patient with a prior myocardial infarction, a patient10 undergoing non-vascular surgery, or a fetus during labor and delivery. No suitable figure
Patent SG-195133-A1 (SG)
Title: Application notifications
Inventor: DONAHUE TYLER J
Filed: 2011-10-09
Abstract: Application notification techniques are described. Implementations are described in which a representation of an application may include notifications that pertain to the application. Techniques are further described which may be used to manage the notifications, including replacement of notifications, use of queues, overrides, selection of notifications based on execution state of an application, cycling a display of a plurality of notifications, cycling a display of different subsets of notifications, examination of a manifest of an application to determine criteria to be used to display the notifications, display priority of the notifications, and so on.
Patent WO-2015199617-A1 (WO)
Title: A monoclonal antibody with t-cell receptor-like specificity that targets epstein-barr infected human tumour cells based on their expression of ebna1
Inventor: MACARY PAUL ANTHONY
IPC: A61K39/42
Filed: 2015-06-24
Abstract: Compositions and methods related to monoclonal antibodies that target Epstein-Barr virus (EBV) associated tumor cells due to binding to HLA/EBNA1 peptide complexes for the detection and targeting of EBV infected tumor cells are provided.
Patent WO-2017058119-A1 (WO)
Inventor: NIJHOF EDWIN
IPC: H02K7/116
Filed: 2016-10-03
Abstract: L'invention concerne un système de production d'énergie comprenant un volant; un moteur disposé pour entrer de l'énergie vers ledit volant, ledit moteur comprenant un système d'engrenages pour commuter entre une entrée à faible vitesse et une entrée à grande vitesse; un générateur en communication avec le volant pour recevoir l'énergie dudit volant; le moteur et le système d'engrenages étant disposés pour initier la rotation du volant à faible vitesse, puis pour commuter vers une vitesse élevée afin de faire fonctionner ledit volant à une vitesse de rotation optimale.
Patent WO-2021225523-A1 (WO)
Title: Systems, devices, and methods for managing contact instances of persons of interest
Inventor: SUN VASAN ABE
IPC: H04W4/029
Filed: 2021-05-05
Abstract: Embodiments relate to systems and methods for managing contact instances. The method includes receiving a candidate contact instance. The candidate contact instance includes first and second information sets for first and second users, respectively. First information set includes a geolocation, timestamp, and first user identifier. Second information set include a geolocation, timestamp, and second user identifier. The method includes performing an exposure assessment process for the candidate contact instance, including deriving a non-contact score. Non-contact score represents a likelihood the first and second users were not physically exposed to one another during the candidate contact instance. Non-contact score is derived in one or more ways, including performing a layout analysis, map analysis, transportation analyses, and/or different levels analysis. The method includes selecting the candidate contact instance as a contact instance in which there is a risk of physical exposure when the non-contact score is below a threshold value.
Patent WO-2022132032-A1 (WO)
Inventor: YANG XIAO
IPC: G06N20/00
Filed: 2021-11-22
Abstract: Selon des modes de réalisation, la présente divulgation concerne un procédé et un dispositif de traitement de traitement d'image de portrait. Le procédé comprend les étapes consistant : à acquérir une image de portrait à traiter ; à entrer ladite image de portrait dans un modèle de traitement d'image, et à acquérir une image rémanente de tête produite par le modèle de traitement d'image, le modèle de traitement d'image étant utilisé pour effectuer un traitement de rémanence sur une zone de cheveux, au-dessus d'une limite prédéfinie, d'un portrait dans l'image de portrait ; le modèle de traitement d'image étant généré par apprentissage en prenant une image de portrait d'échantillon et une image rémanente de tête d'échantillon correspondant à l'image de portrait d'échantillon en tant qu'ensemble de données d'échantillon ; à utiliser un matériau à effet spécial de tête pour rendre l'image rémanente de tête pour obtenir une image de portrait ayant l'effet spécial ajouté ; et afficher l'image de portrait ayant l'effet spécial ajouté. Selon la présente divulgation, le matériau à effet spécial de tête est ajouté à l'image rémanente de tête générée à partir de l'image de portrait à traiter, de telle sorte qu'une mauvaise correspondance ou une liaison non naturelle des cheveux d'origine du portrait dans l'image de portrait et du matériau à effet spécial de tête est évitée, et le matériau à effet spécial de tête est combiné à l'image de portrait plus naturellement.
Patent WO-2022191780-A1 (WO)
Title: A method for assessing the potential effect of therapeutics on an individual
Inventor: LEZHAVA ALEXANDER
IPC: C12Q1/686
Filed: 2022-03-11
Abstract: The invention relates to a method for assessing and evaluating the potential effect of therapeutics on an individual. In particular, the invention uses real-time PCR-based pharmacogenomic assays in assessing such potential effects. In an aspect of the present invention, there is provided a method of assessing or evaluating a subject's likelihood of developing an adverse reaction in response to an administration of a therapeutic agent, or a method of assessing or evaluating a therapeutic agent's efficacy on a subject, the method comprising determining in a single real-time polymerase chain reaction run the presence of a variant in a set of genes consisting of CYP2D6, CYP2C9, CYP2C19 and SLCO1B1 in a sample obtained from the subject, wherein the presence of a variant on any one of the genes in the set of genes is indicative of a risk to an adverse reaction and/or a change in efficacy to the therapeutic agent.
Patent WO-2024005706-A1 (WO)
Title: High performance launcher with cocking hammer
Inventor: CHIA FRANCIS
IPC: F41B11/89
Filed: 2023-03-06
Abstract: A toy projectile launcher including a housing, a launch barrel, an air piston assembly, a trigger, a trigger lever having a distal end portion connected to the launch barrel, a storage cylinder rotatably mounted within the housing and comprising a plurality of projectile holders, wherein each projectile holder is configured to contain a projectile, and a spring that biases the launch barrel away from the storage cylinder. When the trigger is actuated, the trigger lever pulls the launch barrel into engagement with one of the projectile holders of the storage cylinder to form an airtight seal between a rear portion of the launch barrel and the one of the projectile holders.
Patent WO-2023239295-A1 (WO)
Title: Vidéos d'affichage associées à audio sur une page de profil
Inventor: SINHA PARTH VIJAY
IPC: G06F16/783
Filed: 2023-05-24
Abstract: Des modes de réalisation de la présente divulgation concernent une approche pour afficher des vidéos épinglées avec un audio sur une page de profil. Une vidéo et un nom d'un deuxième utilisateur qui génère un audio d'arrière-plan de la vidéo sont affichés à un premier utilisateur. Le nom du deuxième utilisateur peut indiquer une liaison à une page de profil du deuxième utilisateur. Puis, une détection d'une entrée d'utilisateur est effectuée en continu. Si une sélection d'utilisateur au nom du premier utilisateur est détectée, la page de profil du deuxième utilisateur est affichée au premier utilisateur. La page de profil peut comprendre au moins un audio et un nombre prédéterminé de vidéos associées à l'audio. Selon des modes de réalisation de la présente divulgation, une vidéo utilisant l'audio qui est favorisé par l'utilisateur d'origine (par exemple un artiste) de l'audio peut être plus facilement recommandée à la large gamme d'utilisateurs, ce qui permet d'améliorer l'interaction entre la large gamme d'utilisateurs et l'utilisateur d'origine.
Patent TN-2010000073-A1 (TN)
Title: Compositon pharmaceutique contenant un derive de benzene substitue par glucopyranosyle
Inventor: DUGI KLAUS
IPC: A61P3/10
Filed: 2010-02-12
Abstract: L'invention concerne une composition pharmaceutique selon la revendication 1 contenant un dérivé de benzène substitué par glucopyranosyle en combinaison avec un inhibiteur de DPP IV qui est adapté au traitement ou à la prévention d'un ou de plusieurs états choisis dans le groupe comprenant le diabète sucré de type 1, le diabète sucré de type 2, l'intolérance au glucose et l'hyperglycémie. En outre , la présente invention concerne des procédés destinés à prévenir ou traiter les troubles métaboliques et états associés.
Patent TN-2010000460-A1 (TN)
Title: Nouveaux anticorps utiles pour le traitement du cancer
Inventor: HAEUW JEAN FRANCOIS
IPC: C07K16/28
Filed: 2010-10-08
Abstract: La présente invention est relative à de nouveaux anticorps capables de se lier spécifiquement à la protéine humaine CD 151, notamment monoclonaux d'origine murine, chimériques et humanisés, ainsi que les séquences d'acide aminé et nucléiques codant pour ces anticorps. L'invention comprend également l'utilisation de ces anticorps à titre de médicament pour le traitement prophylactique et/ou thérapeutique de cancers ainsi que dans des procédés ou nécessaire de diagnostic de maladies liées à la surexpression de la protéine CD151. L'invention comprend enfin des produits et/ou des compositions comprenant de tels anticorps en association avec des anticorps et/ou des agents anticancéreux ou conjugués avec des toxines et./ou des radioéléments et leur utilisation pour la prévention et/ou le traitement de certains cancers.